BioCentury
ARTICLE | Company News

Axys receives $1.5 million milestone from Merck

February 8, 2001 8:00 AM UTC

AXPH received a $1.5 million milestone payment from MRK related to development of a small molecule inhibitor of cathepsin K to treat osteoporosis under the companies' 1996 agreement, which was recentl...